Protagonist Therapeutics
PTGX
#2251
Rank
A$11.97 B
Marketcap
A$183.41
Share price
-2.11%
Change (1 day)
38.70%
Change (1 year)

EPS for Protagonist Therapeutics (PTGX)

EPS in 2026 (TTM): A$1.69

According to Protagonist Therapeutics 's latest financial reports the company's current EPS (TTM) is A$1.84. In 2025 the company made an earnings per share (EPS) of A-$3.10 a decrease over its 2024 EPS that were of A$6.77.

EPS history for Protagonist Therapeutics from 2016 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$1.69-154.62%
2025A-$3.10-145.76%
2024A$6.77-402.7%
2023A-$2.24-43.08%
2022A-$3.93-3.7%
2021A-$4.0835%
2020A-$3.02-33.33%
2019A-$4.5374.42%
2018A-$2.60-20.74%
2017A-$3.28-45.64%
2016A-$6.03

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
A-$2.04-210.66%๐Ÿ‡บ๐Ÿ‡ธ USA